Ambea AB (publ) (AMBEA.ST)
SEK 98.05
(1.24%)
SEK 98.05
(1.24%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 5.07 SEK | 30.33% |
| 2022 | 3.89 SEK | 54.98% |
| 2021 | 2.51 SEK | -33.95% |
| 2020 | 3.80 SEK | 51.39% |
| 2019 | 2.51 SEK | -36.29% |
| 2018 | 3.94 SEK | 29.61% |
| 2017 | 3.04 SEK | 70.79% |
| 2016 | 1.78 SEK | 559.26% |
| 2015 | 0.27 SEK | -93.49% |
| 2014 | 4.15 SEK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 1.25 SEK | -16.11% |
| 2024 Q2 | 1.10 SEK | -12.0% |
| 2023 Q4 | 1.49 SEK | -35.22% |
| 2023 Q3 | 2.30 SEK | 350.98% |
| 2023 Q1 | 0.77 SEK | 220.83% |
| 2023 Q2 | 0.51 SEK | -33.77% |
| 2023 FY | - SEK | 30.33% |
| 2022 Q2 | 0.91 SEK | 30.0% |
| 2022 FY | - SEK | 54.98% |
| 2022 Q4 | 0.24 SEK | -88.24% |
| 2022 Q3 | 2.04 SEK | 124.18% |
| 2022 Q1 | 0.70 SEK | 255.56% |
| 2021 FY | - SEK | -33.95% |
| 2021 Q1 | 0.49 SEK | -50.0% |
| 2021 Q2 | 0.39 SEK | -20.41% |
| 2021 Q3 | 2.01 SEK | 415.38% |
| 2021 Q4 | -0.45 SEK | -122.39% |
| 2020 Q1 | 0.65 SEK | 71.05% |
| 2020 Q2 | 0.56 SEK | -13.85% |
| 2020 Q4 | 0.98 SEK | -39.13% |
| 2020 Q3 | 1.61 SEK | 187.5% |
| 2020 FY | - SEK | 51.39% |
| 2019 FY | - SEK | -36.29% |
| 2019 Q4 | 0.38 SEK | -77.11% |
| 2019 Q3 | 1.66 SEK | 937.5% |
| 2019 Q2 | 0.16 SEK | 33.33% |
| 2019 Q1 | 0.12 SEK | -72.09% |
| 2018 FY | - SEK | 29.61% |
| 2018 Q4 | 0.43 SEK | -74.85% |
| 2018 Q3 | 1.71 SEK | 71.0% |
| 2018 Q2 | 1.00 SEK | 26.58% |
| 2018 Q1 | 0.79 SEK | 9.72% |
| 2017 Q3 | 1.58 SEK | 464.29% |
| 2017 FY | - SEK | 70.79% |
| 2017 Q4 | 0.72 SEK | -54.43% |
| 2017 Q1 | 0.47 SEK | 147.37% |
| 2017 Q2 | 0.28 SEK | -40.43% |
| 2016 Q1 | 0.27 SEK | 0.0% |
| 2016 FY | - SEK | 559.26% |
| 2016 Q4 | 0.19 SEK | -84.3% |
| 2016 Q3 | 1.21 SEK | 572.22% |
| 2016 Q2 | 0.18 SEK | -33.33% |
| 2015 FY | - SEK | -93.49% |
| 2014 FY | - SEK | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Attendo AB (publ) | 2.34 SEK | -116.667% |
| Humana AB (publ) | 3.68 SEK | -37.772% |
| ProstaLund AB (publ) | -0.25 SEK | 2128.0% |